Advertisement

Ahead of panel review, FDA says Pfizer vaccine looks effective for young kids

Ahead of a public meeting next week to debate whether the shots are ready for the nation's roughly 28 million children, the Food and Drug Administration has posted its analysis of Pfizer's data.

Advertisement